WASHINGTON TRUST Co Acquires 220 Shares of The Clorox Company (NYSE:CLX)

WASHINGTON TRUST Co raised its position in The Clorox Company (NYSE:CLXFree Report) by 33.8% during the second quarter, according to its most recent filing with the SEC. The firm owned 870 shares of the company’s stock after purchasing an additional 220 shares during the period. WASHINGTON TRUST Co’s holdings in Clorox were worth $119,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the stock. CIBC Private Wealth Group LLC raised its stake in shares of Clorox by 0.5% during the fourth quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock worth $1,982,000 after acquiring an additional 66 shares in the last quarter. Lindbrook Capital LLC raised its stake in shares of Clorox by 6.2% during the first quarter. Lindbrook Capital LLC now owns 1,182 shares of the company’s stock worth $181,000 after acquiring an additional 69 shares in the last quarter. First National Bank of Omaha raised its stake in shares of Clorox by 1.5% during the fourth quarter. First National Bank of Omaha now owns 5,975 shares of the company’s stock worth $852,000 after acquiring an additional 86 shares in the last quarter. Diversify Advisory Services LLC increased its stake in shares of Clorox by 3.9% in the second quarter. Diversify Advisory Services LLC now owns 2,441 shares of the company’s stock worth $322,000 after buying an additional 92 shares during the period. Finally, Retirement Planning Group LLC increased its position in Clorox by 4.2% during the 1st quarter. Retirement Planning Group LLC now owns 2,325 shares of the company’s stock valued at $356,000 after purchasing an additional 94 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

CLX has been the topic of several research analyst reports. Wells Fargo & Company lowered their target price on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research note on Wednesday, July 10th. Argus upgraded Clorox to a “hold” rating in a research note on Tuesday, June 4th. TD Cowen began coverage on Clorox in a research note on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 target price on the stock. DA Davidson cut their price target on Clorox from $162.00 to $153.00 and set a “neutral” rating on the stock in a research note on Friday, August 2nd. Finally, BNP Paribas began coverage on Clorox in a research note on Monday, June 24th. They set an “underperform” rating and a $130.00 price target on the stock. Six investment analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $141.94.

Get Our Latest Stock Analysis on CLX

Clorox Price Performance

Shares of CLX stock traded up $1.63 during mid-day trading on Tuesday, reaching $143.42. The stock had a trading volume of 525,658 shares, compared to its average volume of 1,262,243. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $162.43. The company has a market cap of $17.81 billion, a P/E ratio of 73.47, a price-to-earnings-growth ratio of 1.97 and a beta of 0.39. The business has a 50-day simple moving average of $135.47 and a 200 day simple moving average of $142.40. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73.

Clorox Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 30th. Investors of record on Wednesday, August 14th will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.40%. The ex-dividend date is Tuesday, August 13th. This is a boost from Clorox’s previous quarterly dividend of $1.20. Clorox’s dividend payout ratio (DPR) is currently 252.85%.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.